GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (STU:82F) » Definitions » Market Cap

NFL Biosciences (STU:82F) Market Cap : €23.27 Mil (As of Jun. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is NFL Biosciences Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). NFL Biosciences's share price for the quarter that ended in Dec. 2023 was €1.33. NFL Biosciences's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 8.11 Mil. Therefore, NFL Biosciences's market cap for the quarter that ended in Dec. 2023 was €10.78 Mil.

NFL Biosciences's quarterly market cap increased from Dec. 2022 (€10.34 Mil) to Jun. 2023 (€19.25 Mil) but then declined from Jun. 2023 (€19.25 Mil) to Dec. 2023 (€10.78 Mil).

NFL Biosciences's annual market cap declined from Dec. 2021 (€12.14 Mil) to Dec. 2022 (€10.34 Mil) but then increased from Dec. 2022 (€10.34 Mil) to Dec. 2023 (€10.78 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. NFL Biosciences's Enterprise Value for Today is €20.80 Mil.

NFL Biosciences Market Cap Historical Data

The historical data trend for NFL Biosciences's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NFL Biosciences Market Cap Chart

NFL Biosciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial - - 12.14 10.34 10.78

NFL Biosciences Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Market Cap Get a 7-Day Free Trial 12.14 5.50 10.34 19.25 10.78

Competitive Comparison of NFL Biosciences's Market Cap

For the Biotechnology subindustry, NFL Biosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NFL Biosciences's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NFL Biosciences's Market Cap distribution charts can be found below:

* The bar in red indicates where NFL Biosciences's Market Cap falls into.


NFL Biosciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

NFL Biosciences's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=€1.33*8.10677
=€10.78

NFL Biosciences's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=€1.33*8.10677
=€10.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NFL Biosciences  (STU:82F) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

NFL Biosciences Market Cap Related Terms

Thank you for viewing the detailed overview of NFL Biosciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

NFL Biosciences (STU:82F) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NFL Biosciences SA (STU:82F) » Definitions » Market Cap
Comparable Companies
XPAR:ALTHX XPAR:ALPAT XPAR:ALHYG XPAR:ALINT XPAR:FALG XPAR:POXEL XPAR:ALVET XPAR:ALBPS XPAR:ALMDP XPAR:ALQGC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
ALNFL:France 82F:Germany
Address
199 rue Helene Boucher, Castelnau-le-Lez, FRA, 34170
Website
https://www.nflbiosciences.com/
NFL Biosciences SA specializes in the research and development of medicines to combat tobacco addiction that use botanical and pharmaceutical agents. NFL-101 is company's core product, targeting smoking addiction. It is a clinically developed, botanical drug that contains an insignificant amount of nicotine and is composed of well characterized, natural tobacco leaf proteins.

NFL Biosciences (STU:82F) Headlines

No Headlines